K230825

Substantially Equivalent

Smileyscope System (Therapy Mode)

Applicant: Smileyscope Holding, Inc.
Product code: QRA
Advisory panel: Neurology
Date received: 2023-03-24
Decision date: 2023-09-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Austin, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.